Advisory Research’s Global Cord Blood Corporation CO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-39,545
Closed -$191K 368
2019
Q3
$191K Hold
39,545
0.01% 308
2019
Q2
$229K Hold
39,545
﹤0.01% 349
2019
Q1
$278K Hold
39,545
0.01% 326
2018
Q4
$255K Hold
39,545
0.01% 345
2018
Q3
$276K Hold
39,545
﹤0.01% 346
2018
Q2
$375K Buy
39,545
+7,854
+25% +$75.2K 0.01% 332
2018
Q1
$323K Buy
31,691
+6,223
+24% +$63.6K 0.01% 344
2017
Q4
$253K Hold
25,468
﹤0.01% 386
2017
Q3
$283K Sell
25,468
-27,231
-52% -$319K ﹤0.01% 399
2017
Q2
$500K Hold
52,699
0.01% 365
2017
Q1
$351K Buy
52,699
+5,858
+13% +$34.7K 0.01% 378
2016
Q4
$287K Hold
46,841
﹤0.01% 343
2016
Q3
$239K Hold
46,841
﹤0.01% 245
2016
Q2
$269K Hold
46,841
﹤0.01% 235
2016
Q1
$284K Hold
46,841
0.01% 238
2015
Q4
$298K Sell
46,841
-70,969
-60% -$448K ﹤0.01% 255
2015
Q3
$709K Sell
117,810
-10,340
-8% -$64.3K 0.01% 234
2015
Q2
$789K Sell
128,150
-35,698
-22% -$219K 0.01% 251
2015
Q1
$837K Buy
163,848
+4,967
+3% +$24.4K 0.01% 259
2014
Q4
$718K Buy
158,881
+100,260
+171% +$476K 0.01% 283
2014
Q3
$287K Sell
58,621
-7,650
-12% -$37.1K ﹤0.01% 309
2014
Q2
$366K Hold
66,271
﹤0.01% 297
2014
Q1
$265K Hold
66,271
﹤0.01% 307
2013
Q4
$266K Buy
+66,271
New +$264K ﹤0.01% 297

Other funds holding CO

Advisory Research's CO Position: Q4 2019 in Review

Advisory Research sold out of Global Cord Blood Corporation (CO) in Q4 2019, closing a stake of 39,545 shares — an estimated $191K sold.

Advisory Research first reported a position in CO in Q4 2013 and held it in 24 quarters. The position peaked at $837K in Q1 2015. 35 funds tracked by Wall St. Rank hold CO as of Q4 2019.

  • Advisory Research reported no remaining Global Cord Blood Corporation position as of Q4 2019 after selling out during the quarter.
  • Advisory Research sold 39,545 Global Cord Blood Corporation shares in Q4 2019, an estimated $191K.
  • Advisory Research first reported a position in Global Cord Blood Corporation in Q4 2013 and held it in 24 quarters.
  • Advisory Research's Global Cord Blood Corporation position peaked at $837K in Q1 2015.
  • 35 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q4 2019.

Based on Advisory Research's 13F filing for Q4 2019, filed 11 Feb 2020.